Publications by authors named "Michael Droste"

Claim this Profile
C
Corticotroph tumor progression after bilateral adrenalectomy: data from ERCUSYN.
Elena Valassi, Frédéric Castinetti, Amandine Ferriere, Stylianos Tsagarakis, Richard A Feelders, Michael Droste

Endocr Relat Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab in Aggressive Pituitary Adenomas - Experience with 3 Patients.
Katharina Osterhage, Roman Rotermund, Michael Droste, Judith Dierlamm, Wolfgang Saeger

Exp Clin Endocrinol Diabetes· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardised patient education in adrenal insufficiency: a prospective multi-centre evaluation.
Stephanie Burger-Stritt, Annemarie Eff, Marcus Quinkler, Tina Kienitz, Bettina Stamm, Michael Droste

Eur J Endocrinol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German Survey.
Ulf Elbelt, Sven M Schlaffer, Michael Buchfelder, Ulrich J Knappe, Greisa Vila, Michael Droste

J Clin Endocrinol Metab· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma.
Klaus Christian Mende, Teresa Kellner, Stephan Petersenn, Juergen Honegger, Rocío Evangelista-Zamora, Michael Droste

J Clin Endocrinol Metab· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registry.
Elena Valassi, Antoine Tabarin, Thierry Brue, Richard A Feelders, Martin Reincke, Michael Droste

Eur J Endocrinol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?
Stephan Petersenn, Mirjam Christ-Crain, Michael Droste, Reinhard Finke, Jörg Flitsch

Geburtshilfe Frauenheilkd· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy.
Thierry Brue, Anders Lindberg, Aart Jan van der Lely, Ann Charlotte Akerblad, Maria Koltowska-Häggström, Michael Droste

Endocrine· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personality Traits and Physical Complaints in Patients With Acromegaly: A Cross Sectional Multi-Center Study With Analysis of Influencing Factors.
Anca Zimmermann, Rüdiger Zwerenz, Michael Droste, Christof Schöfl, Christian J Strasburger

Front Endocrinol (Lausanne)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.
Elena Valassi, Richard Feelders, Dominique Maiter, Philippe Chanson, Maria Yaneva, Michael Droste

Clin Endocrinol (Oxf)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN.
Elena Valassi, Holger Franz, Thierry Brue, Richard A Feelders, Romana Netea-Maier, Michael Droste

Eur J Endocrinol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry.
Christof Schöfl, David Petroff, Anke Tönjes, Martin Grussendorf, Michael Droste

Pituitary· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.
Elena Valassi, Holger Franz, Thierry Brue, Richard A Feelders, Romana Netea-Maier, Michael Droste

Eur J Endocrinol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly.
Christian J Strasburger, Niki Karavitaki, Sylvère Störmann, Peter J Trainer, Ilonka Kreitschmann-Andermahr, Michael Droste

Eur J Endocrinol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort.
Caroline Sievers, Dorothee M Baur, Anja Schwanke, Michael Buchfelder, Michael Droste

Pituitary· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry.
David Petroff, Anke Tönjes, Martin Grussendorf, Michael Droste, Christina Dimopoulou

J Clin Endocrinol Metab· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of Primary Hypophysitis in Germany.
Jürgen Honegger, Sven Schlaffer, Christa Menzel, Michael Droste, Sandy Werner

J Clin Endocrinol Metab· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Primary Hypophysitis in Germany.
Jürgen Honegger, Michael Buchfelder, Sven Schlaffer, Michael Droste, Sandy Werner

J Clin Endocrinol Metab· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study.
Christof Schöfl, Jürgen Honegger, Michael Droste, Martin Grussendorf, Reinhard Finke

J Clin Endocrinol Metab· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels.
Michael Droste, Julia Domberg, Michael Buchfelder, Klaus Mann, Anja Schwanke

Eur J Endocrinol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases.
Flavius Zoicas, Michael Droste, Bernhard Mayr, Michael Buchfelder, Christof Schöfl

Eur J Endocrinol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control.
Christian Berg, Stephan Petersenn, Harald Lahner, Burkhard L Herrmann, Michael Buchfelder, Michael Droste

J Clin Endocrinol Metab· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change of symptoms and perceived health in acromegalic patients on pegvisomant therapy: a retrospective cohort study within the German Pegvisomant Observational Study (GPOS).
Caroline Sievers, Katja Brübach, Bernhard Saller, Harald J Schneider, Michael Buchfelder, Michael Droste

Clin Endocrinol (Oxf)· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience from the German pegvisomant observational study.
Christian J Strasburger, Michael Buchfelder, Michael Droste, Klaus Mann, Gunter K Stalla

Horm Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis